Yeah, so if we go back over time over the last decade its gone from around 30,000 to just shy of a million people in the US and that equates to somewhere around 7% of adults currently taking or having claimed to have taken GLP-1 medication specifically for weight loss
Useful documentation includes the value, unit, reference range, date, reason for testing, exposure history with timing, relevant symptoms and findings, and the related labs reviewed
Special Populations: Patients with type 2 diabetes should be monitored for hypoglycaemia, especially if taking insulin or sulfonylureas
Psychosom Med 2017;79:224-233
46, 52 AT 1 receptors are expressed in many organ systems, including the circulatory system, the central nervous system and the urinary system, and so on, 53 which are presumed to play key functions in blood pressure homeostasis